tafasitamab-lenalidomide in r/r dlbcl: clinical trial results and real-world data
Published 1 year ago • 259 plays • Length 2:50Download video MP4
Download video MP3
Similar videos
-
1:41
real-world efficacy of tafasitamab lenalidomide in r/r dlbcl & the importance of patient selection
-
2:23
re-mind2: observational study comparing tafasitamab lenalidomide to available therapies in r/r dlbcl
-
2:20
frontmind: tafasitamab lenalidomide r-chop vs r-chop in newly diagnosed high-risk dlbcl
-
3:53
frontmind: tafasitamab lenalidomide r-chop vs r-chop in high-intermediate & high-risk dlbcl
-
2:13
tafasitamab plus lenalidomide post-cd19 car-t is associated with poor outcomes in lbcl
-
2:31
long-term follow up of study of obinutuzumab, polatuzumab vedotin, and lenalidomide in r/r fl
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
21:38
drawing the line: the rationale behind blood tube collection order
-
3:57
finia - see how it works
-
10:07
understanding diffuse large b-cell lymphoma with bruce cheson, md, facp, faaas, fasco
-
3:04
applying molecular understanding of dlbcl to management strategies
-
2:41
an overview of the latest advances in hematology
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:43
interim analysis of the elm-2 study: odronextamab in patients with r/r follicular lymphoma
-
5:04
the role of tp53 & ctdna kinetics in patients with r/r lbcl treated with glofitamab monotherapy
-
1:43
ongoing clinical trials to look out for in lymphoma
-
2:34
the burden of vte in cancer patients: impacts and novel treatments
-
1:18
updates in the treatment of r/r lbcl: promising novel agents in the pipeline
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
2:06
odronextamab in car-t relapsed diffuse large b-cell lymphoma
-
5:44
glofitamab and obinutuzumab in r/r mcl
-
3:36
the real cost of hematological cancer care explained